Clinical Trials
10 trialsNCT07617272 2026-06-01
PARIS-BIO
Region Stockholm
Phase 2 Recruiting
NCT06388720 2026-05-29
IMGeS
National Cancer Center, Korea
Phase 2 Recruiting
NCT07580651 2026-05-12
(CurieInVivo)
CISSS de Chaudière-Appalaches
Phase NA Not yet recruiting
NCT07577895 2026-05-11
TRAP-PAIN
Kayseri Education and Research Hospital
Not yet recruiting
NCT06773806 2026-05-04
CHLOECAPA
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT07181122 2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
NCT07549256 2026-04-24
ProCan
Regionshospital Nordjylland
Phase 2 Not yet recruiting
NCT02711202 2026-04-13
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Phase NA Completed
NCT07470840 2026-03-24
SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT07485114 2026-03-20
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
Recruiting